Phase I/IIa Study of Pharmacokinetics and Safety of Epidiferphane™ and Taxanes in Breast Cancer Patients
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epidiferphane|DRUG: Taxane Chemotherapy
Sponsor: University of Florida
Collaborators: Prana Therapeutics